Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Association Between Intakes of Protein, Calcium and Milk With Gene Expression and Linear Growth of School Aged Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03895151
Recruitment Status : Completed
First Posted : March 29, 2019
Last Update Posted : December 3, 2019
Sponsor:
Collaborators:
Direktorat Riset dan Pengabdian Masyarakat Universitas Indonesia
University of Brawijaya
Information provided by (Responsible Party):
Dr.Umi Fahmida, SEAMEO Regional Centre for Food and Nutrition

Brief Summary:

Protein is one type of nutrients known as the cause of stunting in developing countries since the mid-1970s (1) but then less attention on protein intake with the assumption that protein intake is sufficient. Compilation of published and non-published dietary intake research among Indonesian children aged 3-12 years (2), 0-18 years old (3) and 1-3 years old (3) found that protein intake among Indonesian children was sufficient (4). This finding is also confirmed by some other studies in 6 low-income countries and lead to the conclusion that growth restriction is not due to protein deficiency (5). Since then, micronutrient received main attention for the past 4 decades (1) to improve the health and survival of young children in developing countries. Issues on the need to re-examined protein recently emerge after the paper of Semba (1,6) regarding the low circulating amino acid among stunted children. It was hypothesized that the correlation between the low level of circulating amino acid with linear growth was through the mechanism of rapamycin complex C1 (mTORC1) and general control nonderepressible 2 (GCN2) pathway that contributes in the synthesis of sphingolipids and glycerophospholipids (6). However, the mechanism on how amino acid link to linear growth remains unclear.

Fortification among Asian children revealed that only milk as food vehicles reported a significant effect on linear growth (2). It is likely that the effect on linear growth is influenced not only on micronutrient content of the fortified foods but also on protein and amino acid profiles of milk as the food vehicle.


Condition or disease Intervention/treatment Phase
Nutritional Stunting Nutritional Anemia Nutritional Deficiency Nutrigenetic Nutrigenomic Linear Programming Food Based Recommendation Dietary Supplement: Milk supplementation Other: Food Based Recommendation (FBR) nutrition education Not Applicable

Detailed Description:

Background:

The understanding of stunting has shifted from attention to protein and micronutrients in 60-80s to amino acids and calcium in the past two decades. Amino acids are suspected to be nutrients that determine to stunting because recent studies have shown that growth can be carried out by the information pathway through the mTOR pathway (the mechanistic target of rapamycin). mTOR is a serine/threonine protein kinase from the PI3K family related kinases which are the main subunits of 2 complex proteins, namely mTORC1 and mTORC2. The mTORC1 protein includes 5 main parts for cell growth, nutrition, growth factors, oxygen, energy, and stress. The mTORC2 protein is used in the cytoskeletal organization and cell survival. The activated mTORC1 protein initiates anabolic processes such as synthetic proteins, lipids, and nucleotides and inhibits catabolic processes such as autophagy. mTORC1 consists of three core proteins: mTOR, Raptor (regulatory protein associated with mTOR) and mLST8 (deadly mammals with Sec13 protein 8).

Activation of the mTORC1 pathway as a controller of growth and metabolism is in accordance with the adequacy of intracellular essential amino acids. Deficiency of leucine, isoleucine, and valine determines mTOR downregulation. Inadequate intake of essential amino acids will repress protein and lipid synthesis as well as cell growth that will affect bone and chondral palate growth, skeletal muscle growth, nervous system myelinization, immune function and the size of the organ formed (Saxton & Sabatini, 2017). Research by Semba, et.al (2016) shows that in stunting children's serum, the levels of the nine essential amino acids are very low. Given that the body does not form essential amino acids directly, the intake of amino acids from food becomes very important (Nuss & Tanumihardjo, 2011). Essential amino acids are mostly contained in animal protein, but consumption in developing countries is still limited. Consumption of animal food sources is associated with a lower risk of stunting.

Study of the mTORC1 pathway that has been done in vitro studies and experimental animals. In humans, the evidence of amino acid signaling through the mTORC1 pathway by using metabolomic aspects and proteomic and transcriptomic characteristics is still unknown. Analysis of genes related to MTORC1 pathway may answer this question

The scope of services:

  1. To assess intakes of energy, macronutrients (protein, fat, carbohydrate), calcium and other micronutrients related to growth (zinc, iron, magnesium)
  2. To assess linear growth
  3. To assess gene expression of the mTORC1 pathway in school-age children in Malang, East Java.

The objective of research:

  1. To assess energy and nutrient intake (especially for protein and calcium)
  2. To assess the expression of mTOR gene
  3. To assess the linear growth (height)
  4. To assess the association between intake of protein, calcium, milk with gene expression of mTOR and linear growth of children who received food-based intervention with or without milk with comparable calcium and protein intakes

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Association Between Intakes of Protein, Calcium, and Milk With Gene Expression and Linear Growth of School Aged Children in Malang
Actual Study Start Date : January 24, 2018
Actual Primary Completion Date : June 15, 2019
Actual Study Completion Date : June 30, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Milk supplementation

Children will receive 130 ml fresh milk, 6 days/week for 20 weeks (January-June 2019).

Milk will be provided and delivered by appointed supplier directly to school. Milk will be distributed with name of the student on the bottle - during break time.

Subjects must be consumed with supervision of the teacher at school during the break.

If they can not finish the milk at once, they can store it in the provided cool box. Student then can consume it again before they go home. Teacher have to record the remaining milk in each bottle that corresponds to every child name and record it in the provided form.

Prior to holiday, student will be given the milk according to school leave days.

Enumerators should collect the form every 3 days and make a recap in the provided form.

Dietary Supplement: Milk supplementation
Fresh milk from local farmer. No artificial sweetener and preservatives. Brandless.

Experimental: Food Based Recommendation (FBR) nutrition education
FBR group will received nutrition education delivered by trained teacher under the supervision of researcher/research assistant once a week. Those who received nutrition education is not only the recruited subjects but also includes their classmates.
Other: Food Based Recommendation (FBR) nutrition education
Food Based Recommendation is result of OPTIFOOD WHO that analysed local food to optimize nutritional status according to problem nutrient.

No Intervention: Control
Control group will receive standard nutrition education



Primary Outcome Measures :
  1. Increasing of children height who receive intervention from baseline [ Time Frame: 3 days in end-line of study ]
    Height of the subject will be measured using Shorrboard. Height measurement will be taken twice, the difference between 1st and 2nd measurements should be not more than 0.7 cm. The data analyzed using WHO AnthroPlus to obtain height for age z-score (HAZ) of the subject.


Secondary Outcome Measures :
  1. nutrient intakes [ Time Frame: 3 days in baseline and end-line ]
    Dietary of energy intake, macronutrients, calcium and other micronutrients related to growth will be assessed using 24-hour recall with multiple-pass interviewing technique. The analysis will be performed using Nutrisurvey 2017 with Indonesian food composition table.

  2. VDR Gene Polymorphism of SNP rs4516035 and rs11568820 [ Time Frame: in middle of study (2 months after baseline) ]
    The SNP Genotyping assay analyzed using Real Time PCR and StepOne V2.3 Software. A total of 40 cycles will performed. The cycling steps of the analysis are Hold (95oC, 20s), Denaturation (95oC, 3s), Annealing Extension (60oC, 20s). The total running time was about one and a half hours for 40 cycles.

  3. gene expression of mTORC1 pathway [ Time Frame: 3 days in end-line of study ]
    The expression of 5' TOP genes as biomarker of downstream mTORC1 pathway will be analyzed using RT-qPCR and StepOne V2.3 Software. mRNA quantified by SYBR Green reaction. A total of 40 cycles will performed. The cycling steps of the analysis are UDG activation (50oC, 2min), Dual-Lock DNA polymerase (95oC, 2min), Denaturation (95oC, 3s), Annealing Extension (60oC, 30s). The total running time was about half an hour for 40 cycles.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   8 Years to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Primary school children
  • Willing to take part in the research and taken venous blood sampling as evidence by the signing of an informed consent from the parents
  • Does not suffer from disability
  • No complaint such as diarrhea, vomiting or nausea after drinking milk (based on the information of parents during screening)

Exclusion Criteria:

  • The child not present when taking blood
  • Having a history of bleeding such as hemophilia
  • Children have plans to move schools within the next 6 months from the baseline data collection.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03895151


Locations
Layout table for location information
Indonesia
Universitas Brawijaya
Malang, East Java, Indonesia, 65145
Sponsors and Collaborators
SEAMEO Regional Centre for Food and Nutrition
Direktorat Riset dan Pengabdian Masyarakat Universitas Indonesia
University of Brawijaya
Investigators
Layout table for investigator information
Principal Investigator: Umi Fahmida Fahmida, Dr SEAMEO RECFON
Layout table for additonal information
Responsible Party: Dr.Umi Fahmida, Dr. Umi Fahmida, SEAMEO Regional Centre for Food and Nutrition
ClinicalTrials.gov Identifier: NCT03895151    
Other Study ID Numbers: NGMilkMalang
First Posted: March 29, 2019    Key Record Dates
Last Update Posted: December 3, 2019
Last Verified: December 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Malnutrition
Nutrition Disorders